Neuraxis: Geisinger medical policy coverage for PENFS, effective September 15

NeurAxis announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation PENFS for Geisinger Health Plan, serving 600,000+ enrollees in central Pennsylvania. This medical policy will bring our national total coverage for PENFS to roughly 24 million insured lives, with more decisions from major payers still pending…”We are excited about the coverage expansion with Geisinger Health, an affiliate of the Geisinger Janet Weis Children’s Hospital, located in central Pennsylvania,” said Brian Carrico, President and Chief Executive Officer of NeurAxis. “We continue to make progress in our commercialization of IB-Stim by increasing payer coverage to drive market adoption of our technology. Payers’ acceptance of our PENFS technology is the result of the robust body of published research. We are on track to achieve our stated goal of having medical policy coverage for at least 50M lives by the end of 2024, which will set the stage for a significant revenue and margin ramp in late 2024 and into 2025,” Carrico noted…